Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion type Assertion NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_head.
- NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_provenance.
- NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion evidence source_evidence_literature NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_provenance.
- NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion SIO_000772 11485622 NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_provenance.
- NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion wasDerivedFrom befree-20150227 NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_provenance.
- NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion wasGeneratedBy ECO_0000203 NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_provenance.